Aravive Price Prediction
ARAVDelisted Stock | USD 1.49 0.21 12.35% |
Oversold Vs Overbought
58
Oversold | Overbought |
Using Aravive hype-based prediction, you can estimate the value of Aravive from the perspective of Aravive response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aravive to buy its stock at a price that has no basis in reality. In that case, they are not buying Aravive because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aravive after-hype prediction price | USD 1.49 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Aravive |
Aravive After-Hype Price Prediction Density Analysis
As far as predicting the price of Aravive at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aravive or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aravive, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Aravive Estimiated After-Hype Price Volatility
In the context of predicting Aravive's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aravive's historical news coverage. Aravive's after-hype downside and upside margins for the prediction period are 1.49 and 1.49, respectively. We have considered Aravive's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Aravive is very steady at this time. Analysis and calculation of next after-hype price of Aravive is based on 3 months time horizon.
Aravive Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Aravive is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aravive backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aravive, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 1 Events / Month | 3 Events / Month | Very soon |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.49 | 1.49 | 0.00 |
|
Aravive Hype Timeline
Aravive is presently traded for 1.49. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Aravive is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Aravive is about 0.0%, with the expected price after the next announcement by competition of 1.49. About 39.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aravive recorded a loss per share of 0.76. The entity last dividend was issued on the 16th of October 2018. The firm had 1:6 split on the 16th of October 2018. Given the investment horizon of 90 days the next forecasted press release will be very soon. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.Aravive Related Hype Analysis
Having access to credible news sources related to Aravive's direct competition is more important than ever and may enhance your ability to predict Aravive's future price movements. Getting to know how Aravive's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aravive may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
MGTA | Magenta Therapeutics | (0.02) | 2 per month | 3.40 | 0 | 5.88 | (4.29) | 16.99 | |
ASLN | Aslan Pharmaceuticals | (0.12) | 8 per month | 0.00 | (0.26) | 8.75 | (18.91) | 58.28 | |
AVRO | AVROBIO | 0.05 | 5 per month | 1.89 | 0.02 | 4.11 | (3.17) | 14.20 | |
AGLE | Aeglea Bio Therapeutics | (0.02) | 3 per month | 4.13 | 0.12 | 12.50 | (7.14) | 331.23 | |
AUTL | Autolus Therapeutics | 0.20 | 9 per month | 0.00 | (0.12) | 6.49 | (7.83) | 26.03 |
Aravive Additional Predictive Modules
Most predictive techniques to examine Aravive price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aravive using various technical indicators. When you analyze Aravive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Aravive Predictive Indicators
The successful prediction of Aravive stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aravive, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aravive based on analysis of Aravive hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aravive's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aravive's related companies.
Story Coverage note for Aravive
The number of cover stories for Aravive depends on current market conditions and Aravive's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aravive is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aravive's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Aravive Short Properties
Aravive's future price predictability will typically decrease when Aravive's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aravive often depends not only on the future outlook of the potential Aravive's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aravive's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 36.4 M | |
Cash And Short Term Investments | 53.7 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Aravive Stock
If you are still planning to invest in Aravive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aravive's history and understand the potential risks before investing.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |